On January 17th, Ms. Wang Jinjin, Director of TMT Industry of UBS Securities Investment Bank, Mr. Chen Chuan, Deputy Director, and Mr. Liao Wei, General Manager of Guangzhou Sales Department led a group of people from the core team to visit E-Techco (Qianhai AnyCheck) Shenzhen Headquarters to inspect AI Medical innovation projects, exchange and guide corporate IPO work. Mr. Zhang Guanjing, Chairman and CEO of E-Techco (Qianhai AnyCheck), Dr. Song Yunming, Director of CIO, Mr. Lin Guoxiong, Chief Engineer and General Manager of Investment Department, Dr. Gao Weiming and other core teams accompanied the inspection and explained E-Techco to the visiting team in detail.
During the period, Swiss bank executive team carefully inspected the product development laboratory, the product display display area and the product production assembly workshop, and carefully examined E-Techco (Qianhai AnyCheck) medical intelligence, intelligent testing equipment, medical information, health information. Products and solutions such as chemical and regional health information. In the product display center, Dr. Gao Weiming, Chief Engineer and General Manager of the Investment Department, explained to the Swiss Bank's executive team the E-Techco Group's smart medical product design and development concept, product technology advancement, current market prospects and development plans. The executive team expressed high recognition and appreciation for E-Techco Group's research and innovation capabilities.
At the subsequent symposium, Mr. Zhang Guanjing, Chairman and CEO of E-Techco (Qianhai AnyCheck), extended a warm welcome to the Bank of Switzerland executive team and introduced the development history, business development and development of E-Techco Group. In general, I would like to thank Swiss Bank for its long-term support to E-Techco Group and expressed the hope that the two sides can enhance exchanges and cooperation in strategic cooperation between banks and enterprises in the future. Chairman Zhang Guanjing mentioned that E-Techco Group is an innovative enterprise that is deeply rooted in the medical and health industry and serves the medical information and health care industry with the most advanced technologies such as artificial intelligence, big data and deep learning. We hope to strengthen strategic cooperation with UBS and build E-Techco Group into a "unicorn" hard technology high-tech enterprise and quickly enter the IPO.
Subsequently, the two sides conducted in-depth talks on how to speed up the company's listing work and to make E-Techco Group an advanced model in the smart industry. The Swiss bank delegation also expressed confidence in the future cooperation with E-Techco Group. The delegation stated that E-Techco has continuous innovation capability, deep technical accumulation and high-quality customer service. In the future, both parties can realize the development of smart medical projects through various cooperation modes and support the innovation and development of E-Techco Group. The two sides will cooperate and stand at a higher strategic level to promote new breakthroughs in smart medical care and bring more convenient, efficient, intelligent and accurate AI medical services to Chinese people.